30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Gilead Palo Alto Inc (CVTX)

Track

Stock chart
Ticker: CVTX Exchange: NMQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
SPIEGELMAN DANIEL K
SVP, CFO
3 sales — total 2,807,887 USD
Sale 2 Apr 2009
Value US$2,416,253.15 | Price 63.24 | Shares 139
Sale 2 Apr 2009
Value US$3,223,340.50 | Price 272.35 | Shares 58,101
Sale 2 Apr 2009
Value US$1,183,111.93 | Price 19.91 | Shares 59,423
Sale 2 Apr 2009
Value US$4,357,616.00 | Price 349.68 | Shares 68,824
Sale 2 Apr 2009
Value US$3,680,958.23 | Price 158.37 | Shares 43,050
Sale 2 Apr 2009
Value US$913,987.10 | Price 19.90 | Shares 45,929
Sale 2 Apr 2009
Value US$2,758,438.50 | Price 19.90 | Shares 138,615
Planned sale 10 Dec 2008
Value US$9,248.46 | Price 9.23 | Shares 1,002
Sale 20 Nov 2008
Value US$16,380.00 | Price 8.19 | Shares 2,000
Planned sale 14 Oct 2008
Value US$17,860.00 | Price 8.93 | Shares 2,000
Planned sale 31 Jul 2008
Value US$118,750.00 | Price 9.50 | Shares 12,500
Planned sale 25 Apr 2008
Value US$118,875.00 | Price 9.51 | Shares 12,500
Planned sale 10 Jan 2008
Value US$95,000.00 | Price 9.50 | Shares 10,000
Sale 18 Dec 2007
Value US$67,560.00 | Price 9.01 | Shares 7,500
Planned sale 11 Dec 2007
Value US$38,048.13 | Price 9.63 | Shares 3,951
Planned sale 11 Dec 2007
Value US$146,100.00 | Price 9.74 | Shares 15,000
Planned sale 10 Dec 2007
Value US$80,240.00 | Price 10.03 | Shares 8,000
Planned sale 9 Nov 2007
Value US$25,444.43 | Price 10.19 | Shares 2,497
Sale 16 Aug 2007
Value US$100,900.00 | Price 10.09 | Shares 10,000
Planned sale 17 Jan 2007
Value US$97,510.00 | Price 13.93 | Shares 7,000
Sale 19 Dec 2006
Value US$24,480.00 | Price 13.60 | Shares 1,800
Planned sale 12 Dec 2006
Value US$38,760.00 | Price 12.92 | Shares 3,000
Sale 7 Mar 2006
Value US$196,240.00 | Price 24.53 | Shares 8,000
Sale 3 Nov 2005
Value US$668,065.00 | Price 25.21 | Shares 26,500
Sale 29 Aug 2005
Value US$205,840.00 | Price 25.73 | Shares 8,000
Sale 26 Aug 2005
Value US$564,317.44 | Price 26.24 | Shares 21,506
Buy 14 Mar 2005
Value US$20,360.00 | Price 20.36 | Shares 1,000
Planned sale 16 Dec 2004
Value US$178,953.75 | Price 23.86 | Shares 7,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2009-04-03 2009-04-02 S Sale SPIEGELMAN DANIEL K

SVP, CFO

Officer
139 +24.1%
63.24
US$2,416,253 		139 +24.1% 63.24 US$2,416,253
2009-04-03 2009-04-02 S Sale SPIEGELMAN DANIEL K

SVP, CFO

Officer
58,101 -9.2%
272.35
US$3,223,340 		58,101 -9.2% 272.35 US$3,223,340
2009-04-03 2009-04-02 S Sale SPIEGELMAN DANIEL K

SVP, CFO

Officer
89,471 -40.7%
289.92
US$918,835 		89,471 -40.7% 289.92 US$918,835
2009-04-03 2009-04-02 S Sale LANGE LOUIS G

Chairman & CEO

Executive Director
278,477 -35.6%
19.90
US$5,541,692 		278,477 -35.6% 19.90 US$5,541,692
2009-04-03 2009-04-02 S Sale LANGE LOUIS G

Chairman & CEO

Executive Director
16,154 -4.0%
19.90
US$321,465 		16,154 -4.0% 19.90 US$321,465
2009-04-03 2009-04-02 S Sale LANGE LOUIS G

Chairman & CEO

Executive Director
45,929 -10.7%
19.90
US$913,987 		45,929 -10.7% 19.90 US$913,987
2009-04-03 2009-04-02 S Sale LANGE LOUIS G

Chairman & CEO

Executive Director
138,615 -26.8%
19.90
US$2,758,438 		138,615 -26.8% 19.90 US$2,758,438
2008-12-10 2008-12-10 PlS Planned sale STUART LEWIS J

SVP COMMERCIAL OPERATIONS

Officer
1,002 -7.0%
9.23
US$9,248 		1,002 -7.0% 9.23 US$9,248
2008-12-10 2008-11-20 S Sale STUART LEWIS J

SVP COMMERCIAL OPERATIONS

Officer
2,000 -14.7%
8.19
US$16,380 		2,000 -14.7% 8.19 US$16,380
2008-10-15 2008-10-14 PlS Planned sale BLACKBURN BRENT K

SVP, Drug Discovery & Dev

Officer
2,000 -6.6%
8.93
US$17,860 		2,000 -6.6% 8.93 US$17,860
2008-08-01 2008-07-31 PlS Planned sale BLACKBURN BRENT K

SVP, Drug Discovery & Dev

Officer
12,500 -26.8%
9.50
US$118,750 		12,500 -26.8% 9.50 US$118,750
2008-04-29 2008-04-25 PlS Planned sale BLACKBURN BRENT K

SVP, Drug Discovery & Dev

Officer
12,500 -25.6%
9.51
US$118,875 		12,500 -25.6% 9.51 US$118,875
2008-01-10 2008-01-10 PlS Planned sale BLACKBURN BRENT K

SVP, Drug Discovery & Dev

Officer
10,000 -22.9%
9.50
US$95,000 		10,000 -22.9% 9.50 US$95,000
2007-12-20 2007-12-18 S Sale GUTSHALL THOMAS L Non-Executive Director
7,500 -60.0%
9.01
US$67,560 		7,500 -60.0% 9.01 US$67,560
2007-12-12 2007-12-11 PlS Planned sale BLACKBURN BRENT K

SVP, Drug Discovery & Dev

Officer
3,951 -11.5%
9.63
US$38,048 		3,951 -11.5% 9.63 US$38,048
2007-12-12 2007-12-11 PlS Planned sale BLACKBURN BRENT K

SVP, Drug Discovery & Dev

Officer
15,000 -30.4%
9.74
US$146,100 		15,000 -30.4% 9.74 US$146,100
2007-12-11 2007-12-10 PlS Planned sale SPIEGELMAN DANIEL K

SVP, CFO

Officer
8,000 -46.4%
10.03
US$80,240 		8,000 -46.4% 10.03 US$80,240
2007-11-13 2007-11-09 PlS Planned sale STUART LEWIS J

SVP COMMERCIAL OPERATIONS

Officer
2,497 -31.7%
10.19
US$25,444 		2,497 -31.7% 10.19 US$25,444
2007-08-17 2007-08-16 S Sale BLACKBURN BRENT K

SVP, Drug Discovery & Dev

Officer
10,000 -30.2%
10.09
US$100,900 		10,000 -30.2% 10.09 US$100,900
2007-01-18 2007-01-17 PlS Planned sale SPIEGELMAN DANIEL K

SVP, CFO

Officer
7,000 -61.5%
13.93
US$97,510 		7,000 -61.5% 13.93 US$97,510
2006-12-21 2006-12-19 S Sale MCNEIL BARBARA J Non-Executive Director
1,800 -41.9%
13.60
US$24,480 		1,800 -41.9% 13.60 US$24,480
2006-12-13 2006-12-12 PlS Planned sale SPIEGELMAN DANIEL K

SVP, CFO

Officer
3,000 -46.6%
12.92
US$38,760 		3,000 -46.6% 12.92 US$38,760
2006-03-08 2006-03-07 S Sale MCNEIL BARBARA J Non-Executive Director
8,000 -76.2%
24.53
US$196,240 		8,000 -76.2% 24.53 US$196,240
2005-11-04 2005-11-03 S Sale SPIEGELMAN DANIEL K

SVP, CFO

Officer
26,500 -100.0%
25.21
US$668,065 		26,500 -100.0% 25.21 US$668,065
2005-08-31 2005-08-29 S Sale BLACKBURN BRENT K

SVP, Drug Discovery & Dev

Officer
8,000 -44.5%
25.73
US$205,840 		8,000 -44.5% 25.73 US$205,840
2005-08-30 2005-08-26 S Sale SPIEGELMAN DANIEL K

SVP, CFO

Officer
21,506 -100.0%
26.24
US$564,317 		21,506 -100.0% 26.24 US$564,317
2005-03-15 2005-03-14 B Purchase SHENK THOMAS E Non-Executive Director
1,000 +inf%
20.36
US$20,360 		1,000 +inf% 20.36 US$20,360
2004-12-20 2004-12-16 PlS Planned sale SPIEGELMAN DANIEL K

Senior Vice President and CFO

Officer
7,500 -27.3%
23.86
US$178,954 		7,500 -27.3% 23.86 US$178,954
Explore more

More insider trading research around Gilead Palo Alto Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America